205
Preparatory course for cardiology exam
Lecture: Coronary heart disease II. Guidelines: Prognostic evaluation, scoring systems. Imaging: Nuclear medicine methods (ischemia, viability). Pharmacological therapy and secondary prophylaxis.
Dachau, December 4, 2009
204
p-c-i live Congress
Opening and objectives Lunch symposium 2 Lecture: Drug-eluting stents: State of the art 2009 Closing of Congress
Munich, November 26–27, 2009
203
Schwabinger Heart & Vascular Forum
Lecture: Stent or bypass surgery after COURAGE and SYNTAX
Munich, November 21, 2009
202
Modern diagnostics and therapy of acute coronary syndrome (ACS) Lecture
Altötting, November 10, 2009
201
48th Bavarian Internists’ Congress Cooperation of outpatient specialists with hospitals
Lecture: From the perspective of the outpatient specialist
Munich, November 7, 2009
200
Great Minds
Lecture: DES state of the art: How valid are the data from randomized trials and how applicable are they for new DES platforms?
Istanbul, Turkey, October 30, 2009
199
EL CONGRESO DE LAS ENFERMEDADES CARDIOVASCULARES FOCUS EN EL DIAGNÓSTICO Y TRATAMIENTO DE LAS ENFERMEDADES CORONARIAS / FOCUS ON THE DIAGNOSIS AND TREATMENT OF CORONARY HEART DISEASES
Lecture: Has the approach to coronary revascularization changed after recent clinical trials?
Barcelona, Spain, October 22, 2009
198
The diabetic cardiac patient Continuing education in cooperation with Foundation “The heart-sick diabetic” Professional association of interventional cardiologists e.V.
Lecture: Stent choice in diabetics: Conventional bare-metal stents or drug-eluting stents?
Berlin, October 21, 2009
197
DGK Session of the Conference President Unresolved problems of combining anticoagulation and antiplatelet therapy
Lecture: Cave stent thrombosis: The interventionalist’s perspective
Dresden, October 9, 2009
196
The diabetic cardiac patient Continuing education in cooperation with: Foundation “The heart-sick diabetic” Professional association of interventional cardiologists e.V.
Lecture: PCI in diabetics: What special considerations?
Munich, September 30, 2009
195
ESC Clinical Seminar What every cardiologist should know about drug-eluting stents
Lecture: Current indications for drug-eluting stents.
Barcelona, Spain, September 1, 2009
194
ESC Clinical Seminar, Webcast Take-home messages for practitioners In collaboration with the Council for Cardiology Practice
Lecture: Risk stratification and coronary heart disease.
Barcelona, Spain, September 1, 2009
193
ESC Focus Session
Percutaneous coronary intervention: Antithrombotic therapy Chairperson
Barcelona, Spain, August 30, 2009
192
Symposium Dyspnea: From symptom to diagnosis – The patient in our daily practice (case discussions)
Chair Lecture: Advances in therapy of CHD: A blessing for humanity or a health policy disaster?
Munich, July 25, 2009
191
Atrial fibrillation: The future begins 2009!
Welcome and introduction
Munich, July 15, 2009
190
Medical education “Modern (post) treatment of acute coronary syndrome: What should the general practitioner consider?”
Lecture: “Can the (post) treatment of acute coronary syndrome from a cardiological perspective be further improved?”
Munich, June 24, 2009
189
CARDIOLOGISK VA Joint symposium ESC Council of Cardiology Practice/Private Practicing Cardiologists’ Forum/Norwegian Society of Cardiology
Lecture: When to re(re-)revascularize or have the COURAGE to defer another angio? Are the ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for revascularization applicable to European practice for chronic stable angina?
Tromsø, Norway, June 18, 2009
188
EuroPCR ACC-i2 Summit @ EuroPCR – Unresolved/poorly addressed issues: ACC and EuroPCR/EAPCI initiatives Under the auspices of the American College
Co-chairperson Lecture: Introduction and objectives Roundtable discussion
Barcelona, Spain, May 21, 2009
187
Literaturhaus Munich Heart & Diabetes, Cardiology Today
Lecture: Interventional and surgical therapy of CHD case discussions on the same topic
Munich, May 16, 2009
186
Allgäu Heart and Vascular Days Coronary heart disease
Chair Lecture: Conservative versus interventional therapy of coronary stenosis Commentary: Live case transmission from the Heart and Vascular Center Oberallgäu: PTCA and DE-stenting
Oberallgäu, Ofterschwang, May 14, 2009
185
German Museum Heart & Diabetes, Cardiology Today
Chair, welcome, introduction Lecture: Interventional and surgical therapy of CHD Summary
Munich, May 9, 2009
184
ACC Vascular Access and Closure
Panel Lecture: New generation closure devices: An update
Orlando, USA, March 29, 2009
183
hdz Medical Meeting
Scientific direction Topic: CHD – how would you have decided? Lecture: The modern definition of CHD Lecture: Stent or bypass surgery? Are the newest guidelines already outdated?
Munich, March 21, 2009
182
Symposium “Acute coronary syndrome – intervention and pharmacotherapy”
Session I: Clinical intervention Lecture: Drug-eluting stents – Quo vadis?
Berlin, March 20, 2009
181
Update on Cardiovascular Therapy Workshop III: Cardiological care of chronic coronary patients
Lecture: MRI and CT – new gold standards in coronary diagnostics? Pro and contra
Munich, February 28, 2009
180
JIM
Case study 1: Pharmacology and stent decision in STEMI intervention Lecture: Case 1: A high-risk STEMI patient Lecture: Case conclusion and discussion Lunch Symposium Hot Topics 2 Lecture: Transferability of data between different drug-eluting stents
Rome, Italy, February 12–13, 2009
179
Anaesthesia Today ASS discontinued!! – Postpone surgery!! Problem of perioperative stent thrombosis
Lecture: How long mandatory dual antiplatelet therapy after coronary stent implantation? What do the guidelines say? When can one deviate from the guidelines?
Gräfelfing, February 4, 2009
178
DMP and KVB Diagnosis and therapy “Coronary artery diseases”
Welcome and introduction Lecture: Invasive diagnostics and stenting: What is necessary – what is optimal? Who should be dilated, who should be operated on?
Munich, January 31, 2009
177
The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center Coronary artery disease in diabetic patients
Chair Coronary artery disease in diabetic patients Chair Live case Lecture: How to choose DES in DM?
Dammam, Saudi Arabia, January 13, 2009
176
The 5th International Cardiac Congress of Saud Al-Babtain Cardiac Center and The 20th Scientific Session of the Saudi Heart Association
Chair Al-Khobar
Saudi Arabia, January 12–15, 2009
175
p-c-i live Congress
Opening and objectives
Theme block 3: Stent or bypass surgery?
Opening lecture of day 2: Requirements for modern bypass surgery
Chair
Lecture: State-of-the-art lecture: Modern diagnostics and therapy of CHD
Farewell
Munich, December 4–5, 2008
174
Medica Congress
New cardiological guidelines
Lecture: Percutaneous coronary intervention: Indication, stent selection, outpatient follow-up
Düsseldorf, November 21, 2008
173
ESC – Acute Cardiac Care
Advanced percutaneous coronary interventions
Lecture: Pros and cons of thrombectomy devices in STEMI.
Versailles, France, October 28, 2008
172
DGK Autumn Meeting
Academy Program
Interventional cardiology
Chair
Hamburg, October 9, 2008
171
9th International Symposium Düsseldorf
3rd Generation drug-eluting stents and new PTCA techniques
Lecture: New drug and cell coatings, biodegradable polymer
Düsseldorf, September 19, 2008
170
ESC Pre-Congress Meeting
Current problems in preventive cardiology
Lecture: Is the use of stents appropriate?
Feldafing, August 29, 2008
169
SOLACI
DES Summit I
Lecture: Update on Taxus trials
Meeting the clinical cardiologist I
Lecture: Calcium scoring makes sense for primary prevention
DES: Update and perspectives (Evening symposium)
Lecture: Evidence-based medicine
Case-based crossfire discussion
Lecture: Diabetic patient with multivessel disease. Take-home message
Cancún, Mexico, August 6–8, 2008
168
The 17th Annual Meeting of the Japanese Society of Interventional Cardiology (17th JSIC)
President’s invited lecture
Lecture: Can PCI exceed bypass surgery?
–What improvement is needed to exceed bypass surgery– (tentative)
Lecture: TAXUS Express 2 stent post-marketing surveillance results of initial clinical follow-up (tentative)
Japan, July 3–5, 2008
167
BNK Symposium
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Scientific direction
Lecture: STEMI
Cologne, June 21, 2008
166
BNK Symposium
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Lecture: Case example 1: STEMI
Stuttgart, June 14, 2008
165
hdz – CHD
A variable disease entity with different facets
Welcome & presentation of different facets of CHD
Lecture: Typical angina pectoris: Always catheterization? Stents for everyone?
Munich, June 7, 2008
164
British Cardiovascular Society
Annual Scientific Conference
British Cardiovascular Society (BCS)
European Society of Cardiology (ESC)
British Cardiovascular Intervention Society (BCIS)
Guidelines: Development and delivery
Lecture: PCI guidelines – how we do it
Manchester, UK, June 3, 2008
163
Acute coronary syndrome and stable angina pectoris:
Claims and reality – discussed with you using 5 case examples
Scientific direction
Welcome and moderation
Lecture: STEMI
Hamburg, May 31, 2008
162
Update on Cardiovascular Therapy
Lecture: MRI and CT – new gold standards in coronary diagnostics? Pro and contra
Frankfurt am Main, May 24, 2008
161
EuroPCR
Drug-eluting stents in challenging patients and lesions
Chair: Objective: To review the evidence for using specific drug-eluting stents in challenging patients and lesion types
Take-home message
Symposium: When safety meets efficacy – Nobori drug-eluting stent
Lecture: Nobori 1 results update
TCT @ EuroPCR – Hot topics in interventional cardiology
Under the auspices of the Transcatheter Cardiovascular Therapeutics (TCT)
Chair
Barcelona, Spain, May 13–16, 2008
160
Hot Topic “Cardiology”
Drug-eluting stents (DES): Why – Why not?
Lecture: Position paper of the DGK on efficacy and safety of DES
Berlin, April 11, 2008
159
74th Annual Meeting of the German Society of Cardiology – Heart and Circulatory Research
Invited lecture – “Keynote Lecture”:
Drug-eluting stents – quo vadis?
Mannheim, March 28, 2008
158
Treatment of the patient with myocardial infarction 2008: Optimal reperfusion strategies for STEMI and NSTEMI
Chair
Munich, February 23, 2008
157
LiveCourse 2008
13th Symposium on Interventional Cardiology and Angiology
Under the patronage of the German Society of Cardiology – Heart and Circulatory Research
Lecture: “Off-label” versus “on-label” use of drug-eluting stents: Increased risk, lower benefit
Hamburg, February 2, 2008
156
Dresden Cardiovascular Days 2008
Modern concepts in diagnosis and therapy of cardiovascular diseases
VIII. Drug-eluting stents: Does every patient need a DES?
Lecture: Indication for DES – pro
Dresden, January 27, 2008
155
4th Bochum Symposium on Physiology in the Cardiac Catheterization Lab
Lecture:
Update on drug-eluting stents: Are all the same? What is established?
Bochum, January 25, 2008
154
ICI
Current problems in drug-eluting stents
Lecture: DES efficacy – safety balance – The right to choose
Tel Aviv, Israel, December 3, 2007
153
INNOKARDIO + BNK
Acute coronary syndrome and stable angina pectoris: Claims and reality – discussed with you using 5 case examples
Scientific direction
Welcome and moderation
Lecture: Case example 1: STEMI
Munich, December 1, 2007
152
Focus Session Cardiology
Case presentations: Symptoms, diagnostics, and therapy options
Controversial questions, common and rare diseases
How would you have decided?
Welcome, introduction, session
Munich, October 17, 2007
151
DMP-CHD Continuing Education of KVB
Diagnosis and therapy of coronary artery diseases
Lecture: CHD: invasive diagnosis and treatment
Würzburg, September 29, 2007
150
ESC
Abstract Session
Trials and registries in percutaneous coronary intervention
Chair
Symposium
Implementation of ESC practice guidelines for percutaneous coronary interventions in Europe – impact on long-term outcome. Lessons from the Euro Heart Survey Programme
Lecture: Long-term outcome of PCI in multivessel disease.
Abstract session/Poster session 5
Lecture: Value of cardiac CT in addition to myocardial perfusion scintigraphy.
Take-home messages for practitioners
“Clinical Seminar in collaboration with the Council for Cardiology Practice”
Lecture: Risk stratification and coronary artery disease.
Vienna, Austria, September 2–4, 2007
149
ESC
Abstract:
Final 5-year clinical follow-up of TAXUS II: Long-term anti-restenotic efficacy and safety for both slow- and moderate-release polymer-based paclitaxel-eluting TAXUS stents
Vienna, September 2007
148
ESC
Abstract
Value of cardiac CT in addition to myocardial perfusion scintigraphy
Vienna, Austria, September 2007
147
ESC
Abstract
Gender differences in the application and outcome of PCI, Euro Heart Survey PCI
Vienna, Austria, September 2007
146
hdz Continuing Education Event: New in diagnostics and therapy of CHD
Lecture: Non-obstructive CHD: Why is it important to diagnose?
Munich, July 28, 2007
145
DMP-CHD Continuing Education of KVB
Diagnosis and therapy of “Coronary artery diseases”
Lecture: CHD: invasive diagnosis and treatment; diagnostics also with respect to DMP enrollment; indication for surgery; pros and cons of uncoated and coated stents;
Munich, June 30, 2007
144
Bogenhausen Cardiology Seminar
Lecture: Guideline-based indications for cardiac CT and cardiac MRI
Munich, June 20, 2007
143
Great Minds in Berlin
German-Austrian expert meeting on focused topics in interventional cardiology
Lecture: What do the guidelines say? On what evidence are they based?
Lecture: Difference or equivalence – all a matter of study design?
Moderation: “Long-term outcomes after drug-eluting stents”
Berlin, June 15–16, 2007
142
Austrian Society of Cardiology
Annual Meeting 2007
“Pro-healing stent: New stent developments: GENOUS – EPC capturing technology” WERFEN Austria/ORBUS NEICH
Lecture: How safe are “drug-eluting stents”?
Salzburg, Austria, May 31, 2007
141
talking eyes & more
International symposium
Cardiovascular prevention – “State of the art”
Lecture: “Evidence-based identification of high-risk patients in primary prevention of coronary artery disease”
Nürnberg, May 26, 2007
140
EuroPCR
Late-breaking coronary trials
Panel
Take-home message
Coronary drug-eluting stents: Current questions, future perspectives
Lecture: Debate on duration of dual antiplatelet therapy: 6-month antiplatelet post-coronary drug-eluting stent
Optimizing coronary drug-eluting stent results in diabetics
Chair
Lecture: Introduction and learning objectives
Take-home message
Percutaneous coronary intervention in acute and later phases of myocardial infarction
Lecture: Do we need to update the guidelines?
May 22–24, 2007
139
Medical Continuing Education Event
Lecture: “New guideline on the use of drug-eluting coronary stents – What are the implications for general practitioners’ drug budgets?”
Munich, April 26, 2007
138
137
ACC Roundtable
Topical issues with drug-eluting stents
Co-chair
New Orleans, USA, March 26, 2007
136
ACC
Drug-Eluting Stent Revolution IV
Lecture: DES safety vs. efficacy: Diverse viewpoints on the appropriate utilization of DES, BMS, and CABG
Lecture: Evidence-based medicine indications for DES usage: European recommendations
Roundtable discussion and audience Q&A: Selection of DES vs. BMS vs. surgery
Lecture: Back to the patient: A case-based forum
Lecture: The Case III: Diffuse multivessel disease (Type II diabetes)
New Orleans, USA, March 23, 2007
135
Health policy cardiology 2007
Outpatient cardiology
Chair
Appropriateness of cardiological indications
Lecture: Late stent thromboses: How safe are DES now?
Outpatient cardiology
Lecture: The outpatient cardiologist at the center of the IV: Example CardioPlus
Potsdam, January 23–24, 2007
134
Hot topics in cardiology and cardiac surgery
Lecture: Drug-eluting stents
But more complications?
Mainz, January 17, 2007
133
Symposium “Current Cardiology”
Lecture and response: Are drug-eluting stents safe and effective? Pro
Berlin, December 13, 2006
132
ICI
New stent technologies: Raising the bar on clinical outcomes
Panel
Lecture: The role of drug-eluting stents (DES) in acute myocardial infarction with ST-segment elevation (STEMI)
Tel Aviv, Israel, December 4, 2006
131
BNK Year-End Meeting
Chair
Lecture: Evolution of PCI – pitfalls and highlights
Hamburg, November 25, 2006
130
Scientific Congress: Hypertension 2006
“The hypertensive patient in cardiological practice”
Chair
Lecture: Results of a snapshot survey by BNK
Munich, November 22, 2006
129
Medica Congress
Lecture: Computed tomography
Düsseldorf, November 17, 2006
128
AHA
A new stainless-steel-free stent with potential for artifact-free magnetic resonance compatibility: First clinical experience
Poster
Chicago, USA, November 12, 2006
127
TCT
Clinical trials
Abstract: First five-year clinical follow-up from a randomized trial of a polymer-based, paclitaxel-eluting stent: TAXUS I
Washington, DC, USA, October 23, 2006
126
Atrial fibrillation – Update
3M Continuing Education Events under the patronage of BNK
Scientific direction
Munich, October 18, 2006
125
Chiemgau Cardiology Days
Chair
Lecture: Drug-eluting stents: standard or still in need of improvement?
Gut Ising, September 23, 2006
124
Treatment strategies after stent implantation
Lecture: Current role of clopidogrel in interventional cardiology
Hotel Schloss Hohenstein, Ahorn, October 14, 2006
123
ESC
Experts of the Take-Home Session
Lecture: Coronary artery disease
Barcelona, Spain, September 4, 2006
122
Essen/Mayo meets BNK
Myocardial and valvular heart – Update 2006 for clinic and practice
1st Chairman of BNK
Essen, May 19, 2006
121
EuroPCR
Opening symposium: The great debate on drug-eluting stents
Panel
Late breaking trials and clinical trial updates
How to critically analyze randomized trials and registries
Synthesis and implications for practice
Lectures
Percutaneous cardiovascular intervention in Europe: Looking towards the future
Panel
Lecture: How to actively involve the national working groups
New diagnostic approaches in patients with suspected coronary artery disease
Panel
The role of a healing stent: Safety is mandatory
Chair
CRT @ EuroPCR
Lecture: How to select commercially available drug-eluting stents: Based on guidelines
EuroPCR, May 16–18, 2006
120
Healthcare in Transition
Is the course correct?
Symposium of the Federal Association of Outpatient Cardiologists (BNK)
Summary and outlook
Ludwigshafen am Rhein, May 12, 2006
119
4th Dresden Symposium
"Diabetes mellitus and coronary heart disease – prevention and early diagnosis"
Chair
Lecture: Is calcium scoring meaningful in diabetics?
Dresden, May 6, 2006
118
General Practitioners' Circle Munich
CHD and stent implantation
Lecture: Which patient needs which stent?
Munich, May 4, 2006
117
112th Congress of the German Society of Internal Medicine
Claim and reality in cardiology
Lecture: Pro – implantation of drug-eluting coronary stents is medically indicated and financially feasible
Wiesbaden, April 26, 2006
116
Modern CHD diagnostics: Do we still need nuclear cardiology?
Lecture
Peiting, April 25, 2006
115
DGK Main Session
Hotline 3 Register
Lecture: The HEALING-II study
Mannheim, April 22, 2006
114
DGK
Main session
Simulation training in interventional cardiology – Current role and future perspectives
Chair, welcome, closing remarks
Mannheim, April 22, 2006
113
DGK
Guideline session 2
Chair
Mannheim, April 21, 2006
112
DGK AGIK
Working Group “Interventional Cardiology”
Drug-eluting Stents:
- Are there differences or specific indications?
- What comes next?
Chair
Lecture: The healing stent
Mannheim, April 20, 2006
111
ACC Summit 2006
Live Case Transmission Session II
Panel
Percutaneous coronary intervention guidelines
Lecture: European percutaneous coronary intervention guidelines
Atlanta, USA, March 12–14, 2006
110
BNK Imaging Meetings – vision goes reality
Lecture: Nuclear medicine
Optimized myocardial SPECT diagnostics
Erlangen, March 3–4, 2006
109
Health Policy Kickoff of Cardiology
Controversial Issues 2006
Political roundtable on health policy in cardiology 2006:
Will we be able to solve revenue-side problems on the expenditure side?
Main session I
Chair
Main session II
Chair
Main session III
Chair
Potsdam, March 2, 2006
108
6th International Symposium on Cardiovascular Interventions
3. Coronary Interventions
Lecture: Different DES in complex lesions – are the clinical results still the same?
6. Peripheral artery interventions
Satellite symposium
Lecture: Are all DES the same?
Kitzbühel, Austria, February 20, 2006
107
Guidelines Hot Topic Seminar
Lecture: European guidelines/international guidelines
Frankfurt am Main, February 14, 2006
106
S. Silber, B. Richartz, B. Bischoff, L. Pieper, J. Klotsche, H.-U. Wittchen
Increased waist circumference as a cardiovascular risk factor in Germany: Results in over 55,000 patients
Clinical Research in Cardiology, Suppl., (2006)
105
S. Silber, B. Richartz, B. Bischoff, L. Pieper, J. Klotsche, H.-U. Wittchen
Inadequate pharmacological therapy of CHD in Germany: Results of the DETECT study compared to EUROASPIRE I and II
Clinical Research in Cardiology, Suppl., (2006)
104
S. Silber, B. Bischoff, B. Richartz, L. Pieper, J. Klotsche, H.-U. Wittchen
Different results for the PROCAM score, Framingham score, and the ESC score regionalized for Germany in identifying high-risk coronary patients: Results in 48,623 individuals
Clinical Research in Cardiology, Suppl., (2006)
103
S. Silber, G. Stone
Efficacy and safety of the Taxus stent: combined analysis of 3445 patients from 4 randomized trials
Clinical Research in Cardiology, Suppl., (2006)
102
E. Moroder, P. Lochow, I. Krischke, H. Mühling, A. Schmid, Chr. Willert, B. Richartz, S. Silber
Are the results of randomized trials with paclitaxel-eluting coronary stents transferable to everyday clinical practice?
Clinical Research in Cardiology, Suppl., (2006)
101
S. Silber, B. Richartz, B. Bischoff, A. Schmermund
The risk thresholds for high coronary risk determined by electron beam computed tomography (EBCT) cannot be directly transferred to modern multislice computed tomography (MSCT)
Clinical Research in Cardiology, Suppl., (2006)
100
Spanish Society of Cardiology
Invited lecture:
Outpatient management of heart failure
Barcelona, Spain, October 26, 2005
99
98
ESC
New practice guidelines of the European Society of Cardiology
Lecture: Percutaneous coronary intervention
Stockholm, September 4, 2005
97
S. Silber
Are coronary interventions necessarily inpatient?
Z Kardiol 94: Suppl. 2 (2005) Commentary
96
S. Silber, S. Finsterer, M. Vogel, M. Rothmeier
Improved identification of high-risk coronary patients by combined use of myocardial scintigraphy and calcium plaque scoring: Results in 900 consecutive individuals
Z Kardiol 94: Suppl. 2 (2005)
95
S. Silber, B. Bischoff, A. Schmermund
Does the new multislice computed tomography underestimate coronary calcium scoring compared to the older 4-slice multidetector computed tomography? Results from 8000 patients
Z Kardiol 94: Suppl. 2 (2005)
94
S. Silber, A. Colombo, K.E. Hauptmann, J. Drzewiecki, E. Grube
Clinical results of the TAXUS II study at 3 years: durability of polymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions.
Z Kardiol 94: Suppl. 2 (2005)
93
S. Silber, E. Grube, K. Hauptmann on behalf of the TAXUS-I study participants
3-year results of paclitaxel-eluting coronary stents.
Z Kardiol 94: Suppl. 1 (2005) P 735
92
S. Silber, I. Krischke, P. Lochow, Chr. Drexler, S. Stärk, B. Bosnjak, A. Witzgall
Avoidance of bypass surgery due to in-stent restenosis by intracoronary brachytherapy: Results of a 3-year follow-up.
Z Kardiol 94: Suppl. 1 (2005) V 287
91
S. Silber, S. Böhler, D. Pittrow, H. Glaesmer, J. Klotsche, W. Böcking, W. Kirch, H. Scharnagl, W. März, G. Ruf, H.-U. Wittchen, G. Stalla, H. Lehnert, on behalf of the DETECT study group
Deficits in diagnosis and treatment of patients with diabetes mellitus in general practice: Results of the DETECT study.
Z Kardiol 94: Suppl. 1 (2005) P 988
90
S. Silber, S. Böhler, H. Glaesmer, J. Klotsche, F. Freisinger, D. Pittrow, W. Böcking, W. Kirch, G. Ruf, G. Stalla, H. Lehnert, W. März, H.-U. Wittchen
Undertreatment in antihypertensive and lipid-lowering therapy in general practitioners' offices: Results of the DETECT study
Z Kardiol 94: Suppl. 1 (2005) P 427
89
S. Silber, A. Colombo, A. Banning, K. Hauptmann, E. Grube
Investigation of late stent thromboses 18 months after discontinuation of dual antiplatelet therapy with paclitaxel-eluting coronary stents.
Z Kardiol 94: Suppl. 1 (2005) P 125
88
S. Silber, J. Hamburger, E. Grube, M. Pfisterer, J. Belardi, A. Colombo
Direct Stenting With TAXUS Stents Is as Safe and Effective as After Predilatation.
Z Kardiol : Suppl. 1, (2004) P 720
87
S. Silber, E. Grube, J. Belardi, A. Colombo
Paclitaxel-Eluting Stents in Complex Lesions
Z Kardiol 93: Suppl. 5, (2004) P 299
86
S. Silber, J. Shemesh, N. Weg, H.-C. Yoon
International Multicenter Study to Determine Coronary Calcification Distribution Measured by Multislice CT in 5,345 Individuals.
Z Kardiol : Suppl. 1, (2004) V 1287
85
S. Silber, G. Bauriedel, B. Lauer, P. Siostrzonek, T. Münzel
A Stainless-Steel-Free Stent Made of Niobium With Iridium Oxide (IrOx) Coating: First Results of the LUSTY Study
Z Kardiol 93: Suppl. 5, (2004) P 300
84
S. Silber, Chr. Drexler, I. Krischke, P. Lochow, A. Witzgall
High-Dose vs. Low-Dose Beta Irradiation for In-Stent Restenosis
Z Kardiol : Suppl. 1, (2004) P 771
83
D. Baumgart, R. Bonan, Chr. Naber, P. Serruys, A. Colombo, S. Silber, E. Eeckhout, P. Urban
Successful Reduction of In-Stent Restenosis in Long Lesions With Intracoronary Beta Irradiation – Subanalysis of the RENO Registry.
Z Kardiol 92: Suppl. 1, I/172, (2003)
82
T. Schiele, E. Regar, S. Silber, E. Eeckhout, W. Wijns, A. Colombo, W. Rutsch, D. Meerkin, A. Gershlick, R. Bonan, P. Urban
Clinical and Angiographic Acute and Long-Term Outcomes of Intracoronary Beta Irradiation of Bypass Grafts – A Subgroup Analysis of the Multicenter RENO Registry.
Z Kardiol 92: Suppl. 1, I/199, (2003)
81
S. Silber, A. Schmermund
Detection and Distribution of Coronary Calcification in 4000 Individuals Without Known Coronary Heart Disease (CHD): Results for Multislice CT (MSCT).
Z Kardiol 92: Suppl. 1, I/289, (2003)
80
A. Schmermund, S. Silber
Discordance Between Risk Factors and Extent of Coronary Atherosclerosis: Analysis Using 4-Slice Spiral CT in 3459 Individuals Without CHD.
Z Kardiol 92: Suppl. 1, I/289, (2003)
79
P. Lochow, I. Krischke, C. Meier, H. Mühling, S. Silber
Cardiac Catheterization in Asymptomatic Patients With Coronary Calcification on Multislice CT (MSCT) Is Not Indicated.
Z Kardiol 92: Suppl. 1, I/385, (2003)
78
S. Silber, P. Lochow
Femoral Closure Systems: A Help After Invasive Diagnostics?
Z Kardiol 92: Suppl. 2, II/31, (2003)
77
P. Lochow, I. Krischke, H. Mühling, S. Silber
Do the Control Groups of the ISAR-Stereo-II, RAVEL and SIRIUS Studies Reflect Outcomes for the BX-Velocity Stent in a Cardiology Practice Under Routine Conditions? Results of 438 BX-Velocity Stent Implantations.
Z Kardiol 92: Suppl. 2, II/100, (2003)
76
R. Müller, U. Gerckens, K. E. Hauptmann, S. Silber, E. Grube
The TAXUS I Study With the Paclitaxel-Coated NIRx™ Stent – Angiographic Results and Clinical Follow-Up
Z Kardiol 91: Suppl. 1, I/65, (2002)
75
E. Grube, K. Hauptmann, S. Silber, R. Bach, N. Reifart, A. Colombo, J. Fajadet
Increased Incidence of Stent Thrombosis After Use of a Drug-Eluting Coronary Stent: Results of the SCORE Study.
Z Kardiol 91: Suppl. 1, I/65, (2002)
74
Sigmund Silber, Eric Eeckhout, Antonio Colombo, H. Heuer, J. Schofer, Raoul Bonan
Treatment of In-Stent Restenosis by Combined Use of Cutting-Balloon PTCA and Brachytherapy: Results of the European RENO Registry
Z Kardiol 91: Suppl. 1, I/273, (2002)
73
T. M. Schiele, P. W. Serruys, E. Eeckhout, S. Silber, C. Naber, W. Wijns, A. Colombo, W. Rutsch, D. Meerkin, V. Klauss
^90Sr/^90Y Brachytherapy for Treatment of Coronary Vein Bypasses – A Subgroup Analysis of the RENO Registry (European Surveillance Registry With the Novoste™ Beta-Cath™ System)
Z Kardiol 91: Suppl. 1, I/272, (2002)
72
Silber S., Baumgart D, Colombo A, Serruys P, Meerkin D, Schiele Th, R. Dörr, Kleinertz K, Auch-Schwelck W, Wijns W, Eeckhout E, Urban P
Better Clinical Outcome With Longer Radiation Sources: Final Results of the RENO Registry in 1098 Patients
Z Kardiol 91: Suppl. 1, I/272, (2002)
71
Sigmund Silber, Thomas Schiele, Antonio Colombo, Patrick W. Serruys, Eric Eeckhout, Raoul Bonan, Philip Urban
Pullback Technique With Sr/Y90 Sources for Intracoronary Brachytherapy of Long Coronary Stenoses: A Subanalysis of the RENO Registry
Z Kardiol 91: Suppl. 1, I/273, (2002)
70
Sigmund Silber, Peter Lochow, Josef Finsterer for the MUNICH Registry
Comparison Between Prospective and Retrospective ECG Triggering for Exclusion of Coronary Calcification
Z Kardiol 91: Suppl. 1, I/155, (2002)
69
R. Hoffmann, Med. Clinic I, University of Aachen, G. Herrmann, Med. Clinic, University of Kiel, S. Silber, Cardiac Catheterization Laboratory at Klinik Dr. Müller, Munich, P. Braus, G. Werner, Heart Center Duisburg
Optimal Stent Therapy for Long Coronary Lesions. Randomized Multicenter Comparison of Therapy With One Long Versus Two Short Stents.
Z Kardiol 91: Suppl. 1, I/71, (2002)
68
DGK
Working Group “Cardio-CT” Lecture: For Whom? (Who Benefits and Who Does Not From Coronary Calcium Detection?)
October 18, 2002
67
Munich Symposium on Interventional Cardiology
Lecture: Contemporary Use of Arterial Closure Devices Brachytherapy Chair
Munich, October 11/12, 2002
66
14th Seminar on Applied PTCA
Chair and Lecture: Taxus Studies With Paclitaxel-Coated Stents
Fulda, September 20, 2002
65
Quality Assurance in the Cardiac Catheterization Laboratory Lecture: Quality Assurance in the Cardiac Catheterization Laboratory From the Perspective of the Office-Based Cardiologist
Berlin, September 9, 2002
64
ESC
Council of Cardiology Practice: Present and Future of Cardiology by Practicing Cardiologists Lecture: What Can Be Done as a Practicing Cardiologist? Coronary Angiography and Interventions.
Berlin, September 3, 2002
63
ESC
Recent Clinical Trial Update I: Coronary Disease and Arrhythmias Lecture: START: Two-Year Follow-Up
Berlin, September 2, 2002
62
ESC
Cardiac Computed Tomography: Something New on the Horizon? Lecture: The MUNICH Registry: “Normal” Distribution of Coronary Artery Calcium Measured by 4-Slice Computed Tomography in Over 2000 Asymptomatic Individuals.
Berlin, September 1, 2002
61
Expert Meeting on Interventional Cardiology
Lecture: Intravascular Radiation Therapy: Has It Become Superfluous?
Berlin, June 15, 2002